| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.03. | Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment | ||
| 30.03. | Ipsen appoints Michelle Werner as Executive Vice President, President of North America | ||
| 27.03. | Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development | ||
| 27.03. | PM Society Board welcomes Frankie Everson and Mark Wheeler | ||
| 26.03. | BMS' Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma | ||
| 26.03. | BOOST Pharma appoints Elaine Jones as Board Chair | ||
| 25.03. | Eisai and Biogen's new data shows Alzheimer's patients choose to stay on Leqembi long-term | ||
| 25.03. | PRGN adds OVID Health as Specialist Healthcare Member Agency | ||
| 24.03. | Scotland becomes first part of UK to screen all newborn babies for SMA | ||
| 24.03. | RedSail Technologies appoints Joy Neely as Chief Growth Officer | ||
| 23.03. | Novartis agrees on potential $3bn deal to buy Synnovations's breast cancer treatment | ||
| 23.03. | Prime appoints David Hogben as SVP, Omnichannel Strategy & Delivery | ||
| 20.03. | Department of Health and Social Care and partners launch new funding initiative | ||
| 20.03. | Biologos appoints Hetal Patel as CEO | ||
| 19.03. | Almirall celebrates new offices in China to advance innovation in dermatology | ||
| 19.03. | Lucid Group appoints former Pfizer R&D leader Rod MacKenzie as Board Chair | ||
| 18.03. | Atrogi moves forward in phase 1 trial for oral candidate to improve metabolic and muscle health | ||
| 18.03. | Sandoz appoints Armin Metzger as President of new global unit | ||
| 17.03. | WHO releases new target product profiles for urgently needed antibiotics | ||
| 17.03. | BioDuro appoints Andrew Thomas and Stevan Djuric as Scientific Advisors | ||
| 16.03. | AstraZeneca's Imfinzi approved in EU for early gastric and gastro-oesophageal cancers | ||
| 16.03. | Odyssey Therapeutics appoints H Martin Seidel to Scientific Advisory Board | ||
| 13.03. | MHRA approves Leqselvi for severe alopecia areata | ||
| 13.03. | Athlone Laboratories hosts ministerial visit to discuss the future of critical medicines in Ireland | ||
| 12.03. | Bristol Myers Squibb's Sotyktu approved by US FDA for psoriatic arthritis |